Navigating Multimodality Therapy in Non-Small Cell Lung Cancer: Neoadjuvant-Only Versus Perioperative Immunotherapy, Surgical Imperatives, and Future Approaches.

Authors

Gökce Yavuz, Michael Wang, Jonathan D Spicer, Tina Cascone, José Francisco Corona-Cruz

Published in

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. Volume 46. Issue 3. Pages e519336. Epub Jul 15, 2026.

Abstract

Neoadjuvant and perioperative immunotherapy have redefined the treatment landscape for select patients with early-stage and locally-advanced resectable non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors targeting the PD-1/PD-L1 axis combined with platinum-based chemotherapy have achieved substantially higher rates of pathologic complete response and major pathologic response than chemotherapy alone, translating into meaningful improvements in event-free survival and, in select trials, overall survival. Despite this progress, several clinically important questions remain unanswered, including the relative value of neoadjuvant versus perioperative approaches, the optimal sequencing and duration of therapy, and how best to tailor treatment according to tumor biology, host features, and risk of disease recurrence. Emerging biomarkers such as PD-L1 expression, circulating tumor DNA dynamics, and pathologic response may help refine treatment selection although their role in routine decision making is still evolving. The integration of immunotherapy into curative-intent treatment also has important multidisciplinary implications. Accurate staging, appropriate biomarker testing, thoughtful considerations for multimodal therapy integration throughout the perioperative setting, high-quality surgical resection, and careful response assessment remain essential to maximize the benefit of systemic therapy. This review summarizes the current evidence supporting neoadjuvant and perioperative immunotherapy in resectable NSCLC and discusses key biomarkers, unresolved clinical questions, and the practical implications for multidisciplinary care.

PMID:
42456090
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.